Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance

Clinical Microbiology and Infection

Volumn 20, Issue 12, 2014, Pages O1117-O1120

  van Duin, D ^a   Cober, E D ^b   Richter, S S ^b   Perez, F ^c,d   Cline, M ^b   Kaye, K S ^e   Kalayjian, R C ^f   Salata, R A ^d   Evans, S R ^g   Fowler, V G ^h   Bonomo, R A ^c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f METROHEALTH MEDICAL CENTER   (United States)

^g CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carbapenem resistant Enterobacteriaceae; Multidrug resistance; Urinary tract infection

Indexed keywords

ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE;

ANTIINFECTIVE AGENT; BACTERIAL DNA; CARBAPENEM DERIVATIVE; MINOCYCLINE; TIGECYCLINE;

AGED; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; BACTERIURIA; CHEMISTRY; COHORT ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIURIA; CARBAPENEMS; COHORT STUDIES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MINOCYCLINE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 84920271843     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12714     Document Type: Article

References (10)

1. Braykov NP, Eber MR, Klein EY, Morgan DJ, Laxminarayan R. Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the united states, 1999-2010. Infect Control Hosp Epidemiol 2013; 34: 259-268.
2. van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013; 75: 115-120.
3. Sader HS, Farrell DJ, Flamm RK, Jones RN. Tigecycline activity when tested against bacterial strains from united states medical centers: variation in potency and spectrum since approval for clinical use (2006-2012). Antimicrob Agents Chemother 2014; 58: 2274-2280.
4. Huang TD, Berhin C, Bogaerts P, Glupczynski Y. In vitro susceptibility of multidrug-resistant enterobacteriaceae clinical isolates to tigecycline. J Antimicrob Chemother 2012; 67: 2696-2699.
5. Lopez-Camacho E, Gomez-Gil R, Tobes R et al. Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance. J Antimicrob Chemother 2014; 69: 632-636.
6. van Duin D, Perez F, Rudin SD et al. Surveillance of carbapenem-resistant klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 2014; 58: 4035-4041.
7. Horan TC, Andrus M, Dudeck MA. Cdc/nhsn surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.
8. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12.
9. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-4182.
10. Nigo M, Cevallos CS, Woods K et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 5743-5746.